134 related articles for article (PubMed ID: 10857658)
1. Procedural learning in schizophrenia: further consideration on the deleterious effect of neuroleptics.
Bédard MA; Schérer H; Stip E; Cohen H; Rodriguez JP; Richer F
Brain Cogn; 2000; 43(1-3):31-9. PubMed ID: 10857658
[TBL] [Abstract][Full Text] [Related]
2. [Cognition, schizophrenia and the effect of antipsychotics].
Stip E
Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
[TBL] [Abstract][Full Text] [Related]
3. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
4. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
5. Reduced implicit and explicit sequence learning in first-episode schizophrenia.
Pedersen A; Siegmund A; Ohrmann P; Rist F; Rothermundt M; Suslow T; Arolt V
Neuropsychologia; 2008 Jan; 46(1):186-95. PubMed ID: 17850831
[TBL] [Abstract][Full Text] [Related]
6. N-acetylaspartate (NAA) levels in selected areas of the brain in patients with chronic schizophrenia treated with typical and atypical neuroleptics: a proton magnetic resonance spectroscopy (1H MRS) study.
Szulc A; Galińska B; Tarasów E; Kubas B; Dzienis W; Konarzewska B; Poplawska R; Tomczak AA; Czernikiewicz A; Walecki J
Med Sci Monit; 2007 May; 13 Suppl 1():17-22. PubMed ID: 17507880
[TBL] [Abstract][Full Text] [Related]
7. Impaired motor skill learning in schizophrenia: implications for corticostriatal dysfunction.
Schwartz BL; Rosse RB; Veazey C; Deutsch SI
Biol Psychiatry; 1996 Feb; 39(4):241-8. PubMed ID: 8645770
[TBL] [Abstract][Full Text] [Related]
8. Procedural learning in schizophrenia: reconciling the discrepant findings.
Gomar JJ; Pomarol-Clotet E; Sarró S; Salvador R; Myers CE; McKenna PJ
Biol Psychiatry; 2011 Jan; 69(1):49-54. PubMed ID: 20817152
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients.
Casademont J; Garrabou G; Miró O; López S; Pons A; Bernardo M; Cardellach F
J Clin Psychopharmacol; 2007 Jun; 27(3):284-8. PubMed ID: 17502776
[TBL] [Abstract][Full Text] [Related]
10. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
[TBL] [Abstract][Full Text] [Related]
11. Mild procedural learning disturbances in neuroleptic-naive patients with schizophrenia.
Schérer H; Stip E; Paquet F; Bédard MA
J Neuropsychiatry Clin Neurosci; 2003; 15(1):58-63. PubMed ID: 12556572
[TBL] [Abstract][Full Text] [Related]
12. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics.
Bender S; Grohmann R; Engel RR; Degner D; Dittmann-Balcar A; Rüther E
Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S46-53. PubMed ID: 15052514
[TBL] [Abstract][Full Text] [Related]
13. Selective corticostriatal dysfunction in schizophrenia: examination of motor and cognitive skill learning.
Foerde K; Poldrack RA; Khan BJ; Sabb FW; Bookheimer SY; Bilder RM; Guthrie D; Granholm E; Nuechterlein KH; Marder SR; Asarnow RF
Neuropsychology; 2008 Jan; 22(1):100-9. PubMed ID: 18211159
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of D2- and D4-blocking neuroleptics on the procedural learning of schizophrenic patients.
Bédard MA; Scherer H; Delorimier J; Stip E; Lalonde P
Can J Psychiatry; 1996 Sep; 41(7 Suppl 1):S21-4. PubMed ID: 8884048
[TBL] [Abstract][Full Text] [Related]
15. [The impact of antipsychotic medication on the incidence and the costs of inpatient treatment in people with schizophrenia: results from a prospective observational study].
Kilian R; Angermeyer MC
Psychiatr Prax; 2004 Apr; 31(3):138-46. PubMed ID: 15042477
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
18. Procedural learning in schizophrenia can reflect the pharmacologic properties of the antipsychotic treatments.
Scherer H; Bedard MA; Stip E; Paquet F; Richer F; Bériault M; Rodriguez JP; Motard JP
Cogn Behav Neurol; 2004 Mar; 17(1):32-40. PubMed ID: 15209223
[TBL] [Abstract][Full Text] [Related]
19. [Phases of the menstrual cycle and therapeutic response to neuroleptic therapy in patients with schizophrenia].
Vanurová I; Yamamotová A
Cas Lek Cesk; 2001 Oct; 140(21):668-70. PubMed ID: 11766456
[TBL] [Abstract][Full Text] [Related]
20. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
